The following section aims to assess the endocrine and metabolic factors, focusing on insulin, androgens and AMH (and their interactions) in women with PCOS, diabetes and obesity and how they impact the fetoplacental unit. The gene discussed is AMH; the disease is obesity due to melanocortin 4 receptor deficiency.